1 |
Belkhir K, Cerlati O, Heaugwane D, Tosi A, Benkhaled BT, Brient PL, Chatard C, Graillot A, Catrouillet S, Balor S, Goudounèche D, Payré B, Laborie P, Lim JH, Putaux JL, Vicendo P, Gibot L, Lonetti B, Mingotaud AF, Lapinte V. Synthesis and Self-Assembly of UV-Cross-Linkable Amphiphilic Polyoxazoline Block Copolymers: Importance of Multitechnique Characterization. Langmuir 2022;38:16144-55. [PMID: 36516233 DOI: 10.1021/acs.langmuir.2c02896] [Reference Citation Analysis]
|
2 |
Pozzi S, Scomparin A, Israeli Dangoor S, Rodriguez Ajamil D, Ofek P, Neufeld L, Krivitsky A, Vaskovich-Koubi D, Kleiner R, Dey P, Koshrovski-Michael S, Reisman N, Satchi-Fainaro R. Meet me halfway: Are in vitro 3D cancer models on the way to replace in vivo models for nanomedicine development? Adv Drug Deliv Rev 2021;175:113760. [PMID: 33838208 DOI: 10.1016/j.addr.2021.04.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
|
3 |
Mohammad-hadi L, Mohammad-hadi M. The Applications of PDT and PCI in 3D in vitro Cancer Models. Applications of Minimally Invasive Nanomedicine-Based Therapies in 3D in vitro Cancer Platforms 2021. [DOI: 10.1007/978-3-031-02388-0_6] [Reference Citation Analysis]
|
4 |
Mohammad-hadi L, Mohammad-hadi M. 3D in vitro Cancer Models. Applications of Minimally Invasive Nanomedicine-Based Therapies in 3D in vitro Cancer Platforms 2021. [DOI: 10.1007/978-3-031-02388-0_5] [Reference Citation Analysis]
|
5 |
Mohammad-hadi L, Mohammad-hadi M. Applications of Minimally Invasive Nanomedicine-Based Therapies in 3D in vitro Cancer Platforms. Synthesis Lectures on Materials and Optics 2020;1:1-109. [DOI: 10.2200/s01047ed1v01y202009mop006] [Reference Citation Analysis]
|